First clinical trial of an automated blood drawing and testing device
In the future, robots could take blood samples, benefiting patients and healthcare workers alike.
A Rutgers-led team has created a blood-sampling robot that performed as well or better than people, according to the first human clinical trial of an automated blood drawing and testing device.
The device provides quick results and would allow healthcare professionals to spend more time treating patients in hospitals and other settings.
The results, published in the journal Technology, were comparable to or exceeded clinical standards, with an overall success rate of 87% for the 31 participants whose blood was drawn. For the 25 people whose veins were easy to access, the success rate was 97%.
The device includes an ultrasound image-guided robot that draws blood from veins. A fully integrated device, which includes a module that handles samples and a centrifuge-based blood analyzer, could be used at bedsides and in ambulances, emergency rooms, clinics, doctors’ offices and hospitals.
Venipuncture, which involves inserting a needle into a vein to get a blood sample or perform IV therapy, is the world’s most common clinical procedure, with more than 1.4 billion performed yearly in the United States. But clinicians fail in 27% of patients without visible veins, 40% of patients without palpable veins and 60% of emaciated patients, according to previous studies.
Repeated failures to start an IV line boost the likelihood of phlebitis, thrombosis and infections, and may require targeting large veins in the body or arteries – at much greater cost and risk. As a result, venipuncture is among the leading causes of injury to patients and clinicians. Moreover, a hard time accessing veins can increase procedure time by up to an hour, requires more staff and costs more than $4 billion a year in the United States, according to estimates.
“A device like ours could help clinicians get blood samples quickly, safely and reliably, preventing unnecessary complications and pain in patients from multiple needle insertion attempts,” said lead author Josh Leipheimer, a biomedical engineering doctoral student in the Yarmush lab in the biomedical engineering department in the School of Engineering at Rutgers University–New Brunswick.
In the future, the device could be used in such procedures as IV catheterization, central venous access, dialysis and placing arterial lines. Next steps include refining the device to improve success rates in patients with difficult veins to access. Data from this study will be used to enhance artificial intelligence in the robot to improve its performance.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Global Blood-sampling Robot Market: VEEBOT SYSTEMS INC, Rutgers University, Motomanon July 30, 2021 at 2:12 am
According to the latest research, the Blood-sampling Robot Market size is estimated to be USD xx million in 2027 from USD xx million in 2021, with a change xx % between the previous year and current ...
- Vascular Interventional Surgery Roboton July 19, 2021 at 7:28 am
Stratagem Market Insights have included the latest addition of a global market research report titled Vascular Interventional Surgery Robot Market tits expansive repository. The report studies ...
- Scientists to develop a universal method for the optical diagnosis of kidney failureon December 3, 2020 at 4:52 am
"Unlike other diagnostic methods, this does not require surgical intervention, blood sampling or other invasive procedures. Our proposed approach allows to determine in a matter of minutes whether ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
Automated blood drawing and testing
- Covid can be a reset moment for the retail sectoron August 4, 2021 at 9:35 pm
The pandemic can foster a wave of innovation to create a brighter and more sustainable future for the high street ...
- Dangerous medical implants and deviceson July 30, 2021 at 9:39 pm
Often, the only safety “testing” that occurs is in the bodies ... painful” and the chromium and cobalt levels in his blood “were notably high,” he says.Then he started noticing other ...
- A Preanalytic Blood Separation and Metering System for Qualitative and Quantitative Lateral Flow Biosensorson July 30, 2021 at 5:00 pm
Drawing blood and separating the plasma allows biomarkers to be directly accessed without the need for more costly and invasive surgical techniques (e.g., biopsies). Additionally, this will expand ...
- She risked everything to expose Facebook. Now she’s telling her story.on July 29, 2021 at 9:58 pm
“I know that I have blood on my hands by now,” she wrote ... inauthentic activity”—fake likes and shares produced by automated bots and used to drive up someone’s popularity.
- Smart insulin-delivery patch could revolutionize diabetes management one dayon July 28, 2021 at 5:00 pm
Medtronic’s MiniMed 780G automated insulin dosing system ... “Patients with diabetes draw their blood using a device that measures glucose levels," said the press release. "They then self-administer a ...